Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Susana Banerjee

51-100 of 129 results

View this query on the Wikidata Query Service
The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer

scientific article published in May 2008
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

scientific article published on 17 December 2018
Management of melanomas of the gynaecological tract

scientific article
Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer

scientific article published on June 19, 2014
Gynecological cancer: First-line bevacizumab for ovarian cancer--new standard of care?

scientific article published on 28 February 2012
Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers.

scientific article published on 16 April 2018
Let's address burnout in oncologists and reimagine the way we work

scientific article published on 01 January 2019
Targeted agents and combinations in ovarian cancer: where are we now?

scientific article published on 4 March 2016
Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).

scientific article published on 26 August 2015
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole

scientific article
Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives

scientific article published on 12 August 2019
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial

scientific article published on 16 September 2019
Exploiting the folate receptor α in oncology

scientific article published on 09 March 2020
Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review

scientific article
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer

scientific article published on 12 December 2019
Olaparib for the treatment of relapsed ovarian cancer with a BRCA1/2 mutation

scientific article published on 24 August 2018
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma

scientific article published on 24 August 2020
PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper

article by Gabor Liposits et al published 14 October 2018 in Journal of Geriatric Oncology
Pazopanib in ovarian cancer

scientific article published on 21 August 2015
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

scientific article
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial

scientific article published on 09 January 2019
First-line PARP inhibition in ovarian cancer - standard of care for all?

scientific article published on 01 March 2020
Recent advances in systemic treatments for ovarian cancer

scientific article
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

scientific article published on 01 May 2020
Abstract CT138: Translating preclinical observations to the clinic: Combination of the dual m-TORC1/2 inhibitor AZD2014 and paclitaxel in ovarian and lung cancer

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial

scientific article published on 10 January 2020
From Burnout to Resilience: An Update for Oncologists

scientific article published on 01 May 2018
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.

scientific article
Bevacizumab in cervical cancer: a step forward for survival

scientific article published on 27 July 2017
Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor

scientific article
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours

scientific article published on 09 December 2019
The follow-up of women at high risk for breast cancer relapse

scientific article published on 01 October 2009
Nintedanib in ovarian cancer.

scientific article published on 19 July 2017
Targeting the mitogen-activated protein kinase pathway in low-grade serous carcinoma of the ovary

scientific article published on 29 July 2016
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

scientific article published on 10 March 2020
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

scientific article published on 21 August 2020
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

scientific article
Rhabdomyosarcoma with pseudolipoblasts arising in ovarian carcinosarcoma: a distinctive postchemotherapy morphologic variant mimicking pleomorphic liposarcoma

scientific article published on 22 January 2014
Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International Survey

scientific article published on 06 December 2019
Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.

scientific article published on June 2010
PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

scientific article published on 15 August 2023
Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Progression-free survival versus overall survival in ovarian cancer: where are we now?

scientific article published on 01 December 2012
ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC).

scientific article published in June 2022
Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker

scientific article published on 01 October 2019
Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Paulina is supported by:

About Paulina

Help